Bisdemethoxycurcumin exerts pro-apoptotic effects in human pancreatic adenocarcinoma cells through mitochondrial dysfunction and a GRP78-dependent pathway

Pancreatic cancer is a highly aggressive malignancy, which is intrinsically resistant to current chemotherapies. Herein, we investigate whether bisdemethoxycurcumin (BDMC), a derivative of curcumin, potentiates gemcitabine in human pancreatic cancer cells. The result suggests that BDMC sensitizes ge...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Yang, Haopeng, Fan, Shengjun, An, Yu, Wang, Xin, Pan, Yan, Xiaokaiti, Yilixiati, Duan, Jianhui, Li, Xin, Tie, Lu, Ye, Min, Li, Xuejun
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5347794/
https://ncbi.nlm.nih.gov/pubmed/27845899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.13272
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars